Annette C. Reboli - Concepedia

Author

Annette C. Reboli

Cooper Medical School of Rowan University ORCID

Also Known As

A C Reboli, A. C. Reboli, A. Reboli, A.C. Reboli, ANNETTE REBOLI, Annette C Reboli, Annette C. Reboli, Annette Reboli, Annette C. Reboli, Daniel Kett

Publications

16K

Citations

H-Index

Concepts

All Affiliations

Cooper Medical School of Rowan University Cooper University Hospital University of Alabama at Birmingham Hahnemann University Hospital The University of Texas Health Science Center at Houston

About

Annette C. Reboli is an author at Cooper Medical School of Rowan University specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1K
2	Health Sciences	3	3	454
3	Public Health	3	3	138
4	Education	1	1	17
5	Natural Sciences	1	1	37

Annette C. Reboli

Publications

13.9K

Citations

H-Index

Page 1

	Year	Citations
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Peter G. Pappas, Carol A. Kauffman, David R. Andes, Clinical Infectious Diseases	2015	3.9K
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Peter G. Pappas, Carol A. Kauffman, David R. Andes, Clinical Infectious Diseases	2009	3.2K
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever Thomas J. Walsh, Peter G. Pappas, Drew J. Winston, New England Journal of Medicine	2002	985
Anidulafungin versus Fluconazole for Invasive Candidiasis Annette C. Reboli, Coleman Rotstein, Peter G. Pappas, New England Journal of Medicine	2007	888
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials David R. Andes, Nasia Safdar, John W. Baddley, Clinical Infectious Diseases	2012	788
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis Peter G. Pappas, C. M. F. Rotstein, Robert F. Betts, Clinical Infectious Diseases	2007	628
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases Thomas J. Walsh, John W. Hiemenz, Nita L. Seibel, Clinical Infectious Diseases	1998	622
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008 Michael A. Pfaller, David R. Andes, Daniel J. Diekema, PLoS ONE Path AllianceAntifungal AgentHealth SciencesFungal PathogenAntifungal Agents	2014	398
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis Peter G. Pappas, Beatriz Bustamante, Eduardo Ticona, The Journal of Infectious Diseases	2004	199
Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia David S. Krause, John F. Reinhardt, José A. Vázquez, Antimicrobial Agents and Chemotherapy	2004	178

Page 1